Schizophrenia Research Forum - A Catalyst for Creative Thinking
Home Profile Membership/Get Newsletter Log In Contact Us
 For Patients & Families
What's New
Recent Updates
SRF Papers
Current Papers
Search All Papers
Search Comments
Research News
Conference News
Plain English
Current Hypotheses
Idea Lab
Online Discussions
Virtual Conferences
What We Know
Animal Models
Drugs in Trials
Research Tools
Community Calendar
General Information
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
SRF Team
Advisory Board
Support Us
How to Cite
Fan (E)Mail
The Schizophrenia Research Forum web site is sponsored by the Brain and Behavior Research Foundation and was created with funding from the U.S. National Institute of Mental Health.

Beasley CM, Sutton VK, Taylor CC, Sethuraman G, Dossenbach M, Naber D. Is quality of life among minimally symptomatic patients with schizophrenia better following withdrawal or continuation of antipsychotic treatment? J Clin Psychopharmacol . 2006 Feb ; 26(1):40-4. PubMed Abstract

Comments on Paper and Primary News
Comment by:  William Carpenter, SRF Advisor (Disclosure)
Submitted 22 January 2006 Posted 23 January 2006
  I recommend this paper

There are a number of studies suggesting that a subgroup of patients do very well off medication (see Bola, 2005), but it has been very difficult to define this subgroup, except that good prognosis factors predict good outcome groups. Most importantly, the available data do not indicate how the patients doing well off medication would be doing if they were on medication. The adverse effects of drugs would be avoided, and this is non-trivial for neuroleptic effects of many first-generation antipsychotics and for metabolic effects of many second-generation antipsychotics. The current paper does not address risk/benefit issues, but does report benefit to stable patients continuing antipsychotic drug treatment. This is important, and finding the drug and dose which minimize adverse effects is critical.

Bola JR. Medication-Free Research in Early Episode Schizophrenia: Evidence of Long-Term Harm? Schizophr Bull. 2005 Oct 27. Abstract

View all comments by William Carpenter

Comments on Related News
Related News: News Update: What Does CATIE Mean for Treatment?

Comment by:  Marvin Herz
Submitted 7 February 2006 Posted 8 February 2006

I believe that the results of the CATIE study indirectly support the core principle of treatment, that is, it should be comprehensive, using a biopsychosocial approach. The large number of dropouts is but one example of the limitations of relying on antipsychotic medication alone in the treatment of schizophrenia. We know that psychosocial treatments enhance compliance and overall outcome. See, for example, the study that my colleagues and I conducted on relapse prevention in schizophrenia, which had a small number of dropouts over 18 months (Herz et al., 2000).

Herz MI, Lamberti JS, Mintz J, Scott R, O'Dell SP, McCartan L, Nix G. A program for relapse prevention in schizophrenia: a controlled study. Arch Gen Psychiatry. 2000 Mar;57(3):277-83. Abstract

View all comments by Marvin Herz

Submit a Comment on this Paper
Make a comment on this paper. 

If you already are a member, please login.
Not sure if you are a member? Search our member database.

*First Name  
*Last Name  
Country or Territory  
*Login Email Address  
*Confirm Email Address  
*Confirm Password  
Remember my Login and Password?  
Get SRF newsletter with recent commentary?  
Enter the code as it is shown below:
This code helps prevent automated registrations.

I recommend this paper

Please note: A member needs to be both registered and logged in to submit a comment.


(If coauthors exist for this comment, please enter their names and email addresses at the end of the comment.)


SRF News
SRF Comments
Text Size
Reset Text Size
Email this pageEmail this page

Copyright © 2005- 2014 Schizophrenia Research Forum Privacy Policy Disclaimer Disclosure Copyright